Helios Technologies (HLIO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 May, 2026Executive summary
Annual Meeting scheduled for June 15, 2026, at 8:30 a.m. Central Daylight Time in Tulsa, Oklahoma.
Proxy materials are available online, with options to request paper or email copies at no charge.
Stockholders can attend the meeting virtually or in person using a unique control number.
Voting matters and shareholder proposals
Election of three directors to serve until 2029 and one director until 2027.
Ratification of Grant Thornton LLP as independent auditor for the year ending January 2, 2027.
Advisory vote on Named Executive Officer compensation.
Proposal to amend the 2023 Equity Incentive Plan, increasing shares reserved by 1,000,000.
Other business may be transacted as appropriate.
Board of directors and corporate governance
Four directors nominated: Laura Dempsey Brown, Cary Chenanda, Alexander Schuetz, and Ian Walsh.
Directors will serve until their respective annual meetings or until successors are elected.
Latest events from Helios Technologies
- Strong 3Q25 growth and innovation drive a positive 2025 outlook, supported by a diversified portfolio.HLIO
Investor presentation13 Jul 2026 - Q1 2025 sales fell 8% YoY, but cash flow, margins, and debt reduction remained strong.HLIO
Q1 20258 Jul 2026 - Transformation, margin expansion, and operational resilience drive future growth.HLIO
Baird 2024 Global Industrials Conference8 Jul 2026 - Sequential margin and cash flow gains offset year-over-year sales declines.HLIO
Q2 20248 Jul 2026 - Imminent ARDS therapy launch in Japan and global phase III trial signal major growth ahead.HLIO
Jefferies Global Healthcare Conference 202611 Jun 2026 - Q1 2026 sales up 17% with record margins, cash flow, and a raised full-year outlook.HLIO
Q1 202618 May 2026 - Growth, governance, and sustainability drive key proposals and leadership changes for 2026.HLIO
Proxy filing4 May 2026 - Record Q4 and FY25 results, margin gains, and cash flow set up continued growth in FY26.HLIO
Q4 202527 Apr 2026 - Core 2030 targets $1.6B sales, 25%+ EBITDA margin, and accelerated innovation by 2030.HLIO
Investor Day 202620 Mar 2026